Back to News
Market Impact: 0.5

Morgan Stanley downgrades Nuvoton Technology stock rating to Equalweight

MS
Analyst InsightsAnalyst EstimatesCorporate EarningsCompany FundamentalsArtificial IntelligenceTechnology & InnovationProduct LaunchesCurrency & FX
Morgan Stanley downgrades Nuvoton Technology stock rating to Equalweight

Morgan Stanley downgraded Nuvoton Technology Corp (TPE:4919) from Overweight to Equalweight, significantly reducing its price target to NT$60.00 from NT$85.00. This adjustment reflects concerns over foreign exchange impacts on 2025-2027 earnings estimates, slow revenue contribution from AI initiatives, lukewarm momentum in non-AI segments, increased pricing competition from Chinese rivals, and delayed product launches. Despite these challenges, the firm noted Nuvoton's current valuation at 1.7 times next-twelve-months book value is below its historical average, which prevented an Underweight rating.

Analysis

Morgan Stanley has downgraded Nuvoton Technology Corp (TPE:4919) to Equalweight from Overweight and substantially reduced its price target to NT$60.00 from NT$85.00, signaling significant near-term concerns. The downgrade is driven by a confluence of negative factors, including anticipated adverse foreign exchange impacts on 2025-2027 earnings, intensified pricing competition from Chinese rivals, and operational setbacks from delayed new product launches. Furthermore, the firm notes that momentum in Nuvoton's non-AI business segments remains 'quite lukewarm,' while expected revenue contributions from its artificial intelligence initiatives have yet to materialize. Despite these headwinds, the rating was not lowered to Underweight due to valuation considerations. The stock currently trades at 1.7 times its next-twelve-months book value per share, which represents a notable discount to its historical average of 2.3 times since 2012, suggesting a degree of negative sentiment may already be priced in.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo